OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preclinical evidence for the use of the atypical antipsychotic, brexpiprazole, for opioid use disorder
Julia E.R. Nickols, Serdar Dursun, Anna M.W. Taylor
Neuropharmacology (2023) Vol. 233, pp. 109546-109546
Closed Access | Times Cited: 8
Julia E.R. Nickols, Serdar Dursun, Anna M.W. Taylor
Neuropharmacology (2023) Vol. 233, pp. 109546-109546
Closed Access | Times Cited: 8
Showing 8 citing articles:
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 535-535
Open Access | Times Cited: 8
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 535-535
Open Access | Times Cited: 8
Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
Healthcare (2024) Vol. 12, Iss. 3, pp. 339-339
Open Access | Times Cited: 7
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
Healthcare (2024) Vol. 12, Iss. 3, pp. 339-339
Open Access | Times Cited: 7
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 5
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 5
Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases
Jeran K. Stratford, Megan U. Carnes, Caryn Willis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Jeran K. Stratford, Megan U. Carnes, Caryn Willis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Third-Generation Antipsychotics and Lurasidone in The Treatment of Substance-Induced Psychoses: A Narrative Review
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
(2024)
Open Access | Times Cited: 4
Valerio Ricci, Domenico De Berardis, Giuseppe Maina
(2024)
Open Access | Times Cited: 4
Brexpiprazole Attenuates Aggression, Suicidality and Substance Use in Borderline Personality Disorder: A Case Series
Benedict Francis, Vijay A L Ganasan, Abdul Rasyid Bin Sulaiman
Medicina (2024) Vol. 60, Iss. 2, pp. 283-283
Open Access | Times Cited: 3
Benedict Francis, Vijay A L Ganasan, Abdul Rasyid Bin Sulaiman
Medicina (2024) Vol. 60, Iss. 2, pp. 283-283
Open Access | Times Cited: 3
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study
Ginevra Lombardozzi, Giada Trovini, Emanuela Amici, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 6
Ginevra Lombardozzi, Giada Trovini, Emanuela Amici, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 6
Investigating the Effectiveness of Brexpiprazole in Schizophrenic Patients with Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Study
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.
(2024)
Open Access | Times Cited: 1
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, et al.
(2024)
Open Access | Times Cited: 1
